Cell therapy for hereditary epidermolysis bullosa / 中华皮肤科杂志
Chinese Journal of Dermatology
; (12): 698-702, 2023.
Article
en Zh
| WPRIM
| ID: wpr-994516
Biblioteca responsable:
WPRO
ABSTRACT
Hereditary epidermolysis bullosa (EB) is a rare mutilating and lethal single-gene genodermatosis, and places a heavy burden on society and families. Cell therapy has become a very promising method for the treatment of EB due to its excellent and stable clinical efficacy. This review summarizes progress in laboratory research and clinical application of stem cell- and somatic cell-based therapies in EB in recent years.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Dermatology
Año:
2023
Tipo del documento:
Article